Commentary on Some Recent Theses Relevant to Combating Aging: June 2021.

Area of Science:

• Biomedical Engineering
• Immunology
• Cellular Biology
• Translational Medicine

Background:

• Neurodegenerative diseases like Alzheimer's and Parkinson's involve protein aggregation.
• Diabetic vascular disease is linked to altered macrophage function.
• Human disease modeling benefits from advanced in vitro systems.
• Cellular senescence plays a role in aging and disease.
• T cell exhaustion impairs anti-tumor and anti-pathogen immunity.
• Xenotransplantation holds promise for organ shortages.

Purpose of the Study:

• To summarize recent theses and advancements in key areas of biomedical research.
• To highlight novel approaches in disease modeling and therapeutic development.
• To provide an overview of cutting-edge research across multiple scientific disciplines.

Main Methods:

• Engineering protein disaggregases to target toxic protein aggregates.
• Investigating the effects of hyperglycemia on macrophage immunomodulation.
• Developing and utilizing microvasculature-on-a-chip systems.
• Analyzing the interplay between the immune system and senescent cells.
• Studying the role of transcription factor TOX in T cell exhaustion.
• Exploring translational progress in xenotransplantation.

Main Results:

• Protein disaggregases show potential against alpha-synuclein and amyloid-beta toxicity.
• Hyperglycemia modulates macrophage behavior in diabetic vascular contexts.
• Microvasculature-on-a-chip systems offer new avenues for disease modeling.
• Immune surveillance mechanisms for senescent cells are being elucidated.
• TOX drives a program of CD8+ T cell exhaustion.
• Significant translational advancements are being made in xenotransplantation.

Conclusions:

• Engineering protein disaggregases offers a novel therapeutic strategy for neurotoxicity.
• Understanding macrophage immunomodulation is crucial for managing diabetic vascular complications.
• Microvasculature-on-a-chip technology advances human disease modeling.
• Senescence surveillance is a critical area linking immunity and aging.
• Targeting TOX may reinvigorate T cell responses in chronic infections and cancer.
• Xenotransplantation is moving closer to clinical application.